milliporesigma videos

  1. Strategies To Reduce Regulatory Risks In Gene Therapy 5/15/2020

    Learn how to mitigate regulatory risk for your gene therapy process.

  2. Single-pass Tangential Flow Filtration For Bioprocessing 4/2/2020

    Experiencing bottlenecks in your downstream process? Pellicon® Single-Pass TFF increases your productivity, capacity while reducing costs!

  3. Concentrate Your Product After One Path With Pellicon® Single Pass Tangential Flow Filtration 4/2/2020

    Discover Pellicon® Single-Pass Tangential Flow Filtration, the versatile ultrafiltration technology for process intensification.

  4. Making Data Work 12/16/2019

    What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.

  5. Assuring Viral Safety: Better, Faster, Virus Production 11/14/2019

    Viral safety is tricky when your product is a virus. Learn about the strategies that can help prevent, detect and remove the “bad” viruses from your virus production processes.

  6. Flexible Manufacturing: Better, Faster Virus Production 11/7/2019

    The global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.

  7. Biotherapy Characterization: Cell-Based Assays 7/17/2019

    MilliporeSigma Senior Scientist Agata Burzawa, MSc, explains how we can provide you with rich data sets to help you understand your complex biotherapy faster. Using limited volumes of samples for testing, our scientists employ leading technologies that integrate cytokine release monitoring with immunophenotyping of cells within the same sample.

  8. Biotherapy Characterization: Binding Assays 7/17/2019

    MilliporeSigma Senior Scientist Helen Hsu, Ph.D. describes how, with our custom binding assays, and supported with our comprehensive off-the-shelf Fc gamma receptor binding assays, we can help you optimize your mAb production, from clone development through upstream and downstream processes.

  9. Explore What's Next: Product Characterization 7/17/2019

    Newer, high-resolution analytical techniques help answer questions regarding product heterogeneity and drug functions, and help assess for product-related aggregates and impurities.

  10. Virus Risk Mitigation In The Development Of Biological Medicinal Products: A Global Regulatory Perspective Vaccine Cell Bank And Virus Seed Characterization 10/25/2018

    An overview of the regulatory requirements given in the latest guidance documents as well as a description of new technologies for determining the identity of cell substrates and virus seed stocks and detecting adventitious agent contamination.